Aristotle Atlantic Partners, LLC Sage Therapeutics, Inc. Transaction History

Aristotle Atlantic Partners, LLC

$3.08 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $1.67 Million - $2.45 Million	41,107 Added 26.26%	197,626 $9.29 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $15,727 - $19,652	422 Added 0.27%	156,519 $6.57 Million
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $12,268 - $16,615	-381 Reduced 0.24%	156,097 $5.95 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $43,900 - $58,847	1,360 Added 0.88%	156,478 $6.13 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $82,972 - $114,539	3,015 Added 1.98%	155,118 $5.01 Million
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $37,036 - $55,126	1,206 Added 0.8%	152,103 $5.04 Million
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $385,164 - $489,614	-10,393 Reduced 6.44%	150,897 $6.42 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $3,422 - $4,876	85 Added 0.05%	161,290 $7.15 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $7,902 - $11,417	144 Added 0.09%	161,205 $9.16 Million
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $18,086 - $24,770	256 Added 0.16%	161,061 $12.1 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $206,479 - $314,827	3,535 Added 2.25%	160,805 $13.9 Million
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $3.57 Million - $5.43 Million	86,887 Added 123.45%	157,270 $9.61 Million
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $403,756 - $671,370	15,559 Added 28.38%	70,383 $2.93 Million
Q1 2020 May 14, 2020	SELL	$26.15 - $77.24 $334,432 - $987,822	-12,789 Reduced 18.92%	54,824 $1.57 Million
Q4 2019 Feb 13, 2020	BUY	$60.18 - $154.77 $3.23 Million - $8.3 Million	53,603 Added 382.61%	67,613 $4.88 Million
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $15,011 - $20,325	107 Added 0.77%	14,010 $1.97 Million
Q2 2019 Aug 13, 2019	SELL	$157.85 - $183.09 $7,261 - $8,422	-46 Reduced 0.33%	13,903 $2.55 Million
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $181,607 - $332,700	2,033 Added 17.06%	13,949 $2.22 Million
Q4 2018 Feb 13, 2019	BUY	$81.94 - $139.71 $263,519 - $449,307	3,216 Added 36.97%	11,916 $1.14 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $1.22 Million - $1.53 Million	8,700 New	8,700 $1.36 Million

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

48.2M

Call Options Held

854K

Put Options Held

195K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Account